Clinical trial
Efficacy and Safety of Miltefosine or Thermotherapy for Cutaneous Leishmaniasis…
NCT00471705 · Universidad de Antioquia, Other · Completed
Key facts
| NCT number | NCT00471705 |
|---|---|
| Title | Efficacy and Safety of Miltefosine or Thermotherapy for Cutaneous Leishmaniasis in Colombia. |
| Official title | Phase 3 Open-label Study of Efficacy and Safety of Miltefosine or Thermotherapy vs Glucantime for Cutaneous Leishmaniasis in Colombia. |
| Lead sponsor | Universidad de Antioquia, Other |
| Collaborators | Dirección de Sanidad del Ejército de Colombia (DISAN) Ministerio de Salud y Protección Social, Colombia |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cutaneous Leishmaniasis |
| Intervention type | Device, Drug |
| Interventions | Miltefosine, Thermotherapy, Glucantime® |
| Enrollment | 437 |
| Start date | Jun 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Dec 1, 2009 |
| First posted | May 10, 2007 |
| Last update posted | Jan 16, 2019 |
| Countries | Colombia |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: